GlaxoSmithKline Consumer Nigeria Plc Announces Board Meeting Date and Closed Period


Thursday, February 22, 2018 /10:20 AM / NSE 

This is to notify the General Public that the Board of Directors of GlaxoSmithKline Consumer Nigeria plc will meet on Thursday 8th March 2018 to consider and approve:

1. The 2017 Audited Financial Statements

2. The amount to be recommended to members as dividend at the next Annual General Meeting and

3. Fix the date and venue of the Annual General Meeting.

The General Public will be informed of the Board's decisions immediately after the meeting.

The General Public should take note that the closed period for dealing in the Company's securities by the Directors, Managers or connected persons shall commence from Wednesday 21st February 2018 and shall terminate 24 hours after release of the result to the Nigerian Stock Exchange.

Related News

1.     GLAXOSMITH declares N651.61 Million Loss in Q3 2017 Result,(SP:N25.20k)

2.    GLAXOSMITH declares N21.71 million PAT in Q2'17 Result,(SP:N20.00k)

3.    GLAXOSMITH declares N8.26 million Loss in Q1 2017 Result,(SP:N14.09k)

4.    GSK Consumer Nig. Plc positions for sustainability, with focus on consumer healthcare portfolio

5.    GLAXOSMITH declares N4.20 billion PAT in 2016 Audited Result,(SP:N0.87k)

Related News